Subscribe To
cancervax ceo ryan davies discusses the company’s growing pipeline of cancer treatments
The Company’s development pipeline now includes three projects with UCLA LEHI, Utah, Sept. 14, 2023 (GLOBE NEWSWIRE) — ...
September 14, 2023, 7:01 am
World renowned biomedical professor jonathan lakey joins cancervax board of advisors
Dr. Lakey has been recognized nationally and internationally for his groundbreaking research in cell and tissue transplantation for patients suffering...
July 27, 2023, 2:01 am
Biotech executive michael smith discusses the fda drug development process with cancervax ceo ryan davies
Michael Smith comments on the growth of immunotherapy and sees the required FDA development phases as a benefit to small biotech firms such as ...
June 16, 2023, 7:01 am
cancervax launches $10 million funding round
Proceeds from the SEC qualified Reg A+ offering will allow the Company to continue work on its breakthrough cancer treatments LEHI, Utah, June 14, 202...
June 14, 2023, 7:01 am
cancervax reports positive progress on kids cancer immunotherapy treatment
UCLA research team has successfully created 7 pre-clinical monoclonal antibody candidates for targeting Ewing sarcoma LEHI, Utah, June 12, 2023 (GLOBE...
June 12, 2023, 4:27 pm